Comparison of Candesartan vs Amlodipine Comparison of ...
Comparison of Candesartan vs Amlodipine Comparison of ...
Comparison of Candesartan vs Amlodipine Comparison of ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
All-cause mortality<br />
(CASE-J Primary endpoint)<br />
Proportion <strong>of</strong> patients<br />
with event (%)<br />
16<br />
14<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
VALUE (Valsartan) CASE-J (<strong>Candesartan</strong>)<br />
4%<br />
HR = 1.04 (95% ( % CI = 0.94–1.14) )<br />
p= 0.45<br />
0 12 24 36 48 60 66<br />
5<br />
4<br />
3<br />
2<br />
1<br />
0<br />
CASE-J (<strong>Candesartan</strong>)<br />
Proportion <strong>of</strong> patients<br />
with event (%)<br />
15%<br />
HR=0.85 (95% CI 0.62-1.16)<br />
p=0.303 p<br />
0 12 24 36 48<br />
Time (months) Vl Valsartan-based t b d regimen i<br />
<strong>Amlodipine</strong>-based regimen<br />
Atacand ®<br />
-based regimen